J&J Unit Hit With $3M Jury Verdict In Topamax Row

Law360, Los Angeles (March 7, 2014, 8:15 PM EST) -- A Pennsylvania trial jury on Friday returned a $3 million verdict against a Johnson & Johnson unit in a case accusing the company of failing to warn a woman of the risk of birth defects when using its anti-epilepsy drug Topamax during pregnancy.

Attorneys representing the Wisconsin family of 5-year-old Payton Anderson had told the Philadelphia County Court of Common Pleas on Tuesday that Janssen Pharmaceuticals Inc. didn't update Topamax's label to reflect data showing that the drug resulted in increased incidents of cleft lips and...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.